# ZITUVIMET

NDC: 70710-1787
Generic name: Sitagliptin and Metformin Hydrochloride
Labeler / Manufacturer: Zydus Pharmaceuticals (USA) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20240314

FDA application: NDA216743

## Active ingredients

- METFORMIN HYDROCHLORIDE: 1000 mg/1
- SITAGLIPTIN: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1787"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1787
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeda90a0-4941-4716-8684-f9f12cbdf3af